Lazard Asset Management LLC Collegium Pharmaceutical, Inc Transaction History

Lazard Asset Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $258,617 - $376,437	12,222 New	12,222 $376,000
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $602,215 - $878,697	-37,312 Reduced 92.9%	2,851 $66,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $136,944 - $178,045	8,858 Added 28.3%	40,163 $643,000
Q2 2022 Aug 09, 2022	BUY	$14.22 - $20.88 $210,413 - $308,961	14,797 Added 89.64%	31,305 $554,000
Q1 2022 May 13, 2022	SELL	$17.2 - $22.5 $76,144 - $99,607	-4,427 Reduced 21.15%	16,508 $336,000

Q4 2021 Feb 09, 2022	BUY	$17.5 - $21.35 $366,362 - $446,962	20,935 New	20,935 $391,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $49,895 - $71,371	-2,811 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$21.74 - $25.28 $166,615 - $193,745	-7,664 Reduced 73.16%	2,811 $66,000
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $493,685 - $669,360	-25,646 Reduced 71.0%	10,475 $248,000
Q4 2020 Feb 11, 2021	BUY	$17.83 - $22.29 $70,357 - $87,956	3,946 Added 12.26%	36,121 $723,000
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $240,424 - $317,213	-15,236 Reduced 32.14%	32,175 $669,000
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $734,396 - $1.11 Million	47,411 New	47,411 $829,000
Q3 2018 Nov 13, 2018	SELL	$14.16 - $24.3 $119,014 - $204,241	-8,405 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$18.15 - $29.21 $152,550 - $245,510	8,405 New	8,405 $214,000

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.57B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.